4d Molecular Therapeutics
Clinical trials sponsored by 4d Molecular Therapeutics, explained in plain language.
-
One-Time gene shot may slash eye needles for Diabetes-Related vision loss
Disease control OngoingThis study tests a gene therapy called 4D-150 for people with diabetic macular edema, a condition that causes vision loss due to diabetes. The goal is to see if a single injection of the gene therapy can reduce the need for frequent eye injections over two years. About 72 adults …
Phase: PHASE2 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:10 UTC
-
One shot could replace dozens: gene therapy trial for blinding eye disease
Disease control OngoingThis phase 3 trial tests a single injection of 4D-150 gene therapy in 480 adults with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if one treatment can control the disease and reduce the need for frequent eye injections over two y…
Phase: PHASE3 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:56 UTC